by CytoPrevent | May 11, 2018 | Studies
Mari A. Bernabeu-MartõÂnez, Mateo Ramos Merino, Juan M. Santos Gago, Luis M.AÂ lvarez Sabucedo, Carmina Wanden-Berghe, Javier Sanz-Valero Abstract: Objective: To review the scientific literature related to the safe handling of hazardous drugs (HDs). Method:...
by CytoPrevent | Nov 17, 2017 | Studies
Sophie Ndaw, Alain Robert, Claire Ricolfi, Flavien Denis, Philippe Marsan Abstract: Les médicaments cytotoxiques utilisés dans les traitements des cancers présentent une toxicité intrinsèque, du fait de leurs propriétés génotoxiques, tératogènes et...
by CytoPrevent | Sep 3, 2017 | Studies
Maximilien Lefebvre, Nicolas Simon, Michèle Vasseur, Ousseini Sidikou, Christine Barthélémy, Bertrand Décaudin and Pascal Odou Abstract: Purpose: The aims of this study were to propose a simple methodology to assess the rinsing volume of syringe...
by CytoPrevent | Aug 2, 2016 | Studies
Seth Eisenberg Abstract: The risks associated with hazardous drug (HD) handling have been well documented in the literature, dating back more than 35 years (Centers for Disease Control and Prevention, 2004; Crudi, Stephens, & Maier, 1982; Lorente et al.,...
by CytoPrevent | May 1, 2016 | Studies
Amy Callahan, DNP, RN, CRNP, AOCNS®, Nancy J. Ames, RN, PhD, Mary Lou Manning, PhD, CRNP, CIC, FAAN, Kate Touchton-Leonard, MA, Li Yang, MS, and Gwenyth R. Wallen, RN, PhD Abstract: Purpose/Objectives—To identify factors associated with oncology nurses’ use of...
by CytoPrevent | Apr 12, 2016 | Studies
Pablo Martín Lancharro, Nuria de Castro-Acuña Iglesias, Francisco-Javier González-Barcala, José Domingo Moure González Abstract: Objective: Provide updated evidence and learn about the actions that must be implemented in order to prevent the...